The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,908,515 in first-year total cost, median $775,102.
Most frequent study sections
- Special Emphasis Panel[ZHD1 DSR-L (50)]3
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF KANSAS MEDICAL CENTER1
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Mechanisms of actions(s) of simvastatin in uterine leiomyoma1R01HD094380-01 | BORAHAY, MOSTAFA A. | JOHNS HOPKINS UNIVERSITY, MD | $831,387 | ZHD1 |
| 2018 | Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids1R01HD094378-01 | AL-HENDY, AYMANBOYER, THOMAS G | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $775,102 | ZHD1 |
| 2018 | Small molecule GPR10 antagonists for the treatment of uterine fibroids1R01HD094373-01 | CHENNATHUKUZHI, VARGHEESE MANIGEORG, GUNDA I.RAJKOVIC, ALEKSANDAR | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $302,026 | ZHD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.